Protagenic Therapeutics's total assets for Q4 2025 were $2.13M, a decrease of -0.59% from the previous quarter. PTIX total liabilities were $6.82M for the fiscal quarter, a -29.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.